ArticleScientific reports2026
Improving the elevated temperature behaviour of foamed concrete through nano titania addition and microstructure control.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the effectiveness of nano-titania (NT) as a nano-additive for enhancing the performance and elevated-temperature resistance of foamed concrete (FC). The novelty of this research lies in the comprehensive evaluation of the residual mechanical, transport, thermal, and microstructural behaviour of NT-modified FC after exposure to temperatures of up to 800 °C. NT was incorporated at dosages of 0.5-2.0% by weight of cement, and the performance of the resulting FC was assessed in terms of fresh-state properties, shrinkage, mechanical strength, ultrasonic pulse velocity, transport behaviour, thermal properties, and microstructural characteristics. The results showed that NT reduced workability and shortened setting time, while significantly improving the overall performance of FC under both ambient and elevated-temperature conditions. Among the tested mixtures, the incorporation of 1.5% NT provided the optimum performance. At room temperature, this dosage increased the compressive strength by approximately 40% compared with the control mix. More importantly, after exposure to 800 °C, the residual compressive strength ratio increased markedly from 18% for the control FC to 57% for the FC containing 1.5% NT, indicating a substantial enhancement in thermal resistance. NT also improved the pore structure by reducing the average pore diameter from 580 to 440 µm at 20 °C and from 820 to 620 µm at 800 °C, which contributed to lower permeability and porosity, as well as improved thermal stability. Microstructural observations from SEM and MIP confirmed that NT promoted a denser and more homogeneous matrix through pore refinement and improved hydration development, leading to enhanced residual performance after high-temperature exposure. Overall, the findings demonstrate that NT is an effective nano-modifier for producing FC with superior strength, durability, and fire resistance, with 1.5% NT identified as the optimum dosage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.